Treating bifurcation lesions

To compare the result and safety of the Axxess biolimus-eluting stent with the second-generation drug-eluting stent (DES) in the treatment of bifurcation lesions. The result and safety of the Axxess biolimus-eluting stent were better than DES in treating bifurcation lesions. The present study suggests that the Axxess stent may represent a valid alternative approach for treating bifurcation lesions.

11p viwinter2711 18-10-2021 8 0   Download